apposters.com
Future Ventures (San Francisco)
Edit

Future Ventures (San Francisco)

https://www.future.ventures
Last activity: 29.06.2026
Active
Invests in categories: HealthTechBioTechAIFinTechPlatformRoboticsTechnologyAgriTechITSoftware
We support passionate founders who are forging the future. For the past 25 years, we have backed the
Portfolio
43
Mentions
35
Employees: 1-10
Investment Stage: Series A

Portfolio 43

DateNameWebsiteTotal RaisedLocation
29.08.2025Commonweal...cfs.energy$2.86BUnited Sta...
19.08.2025The Better...bettermeat.co$40.5MUnited Sta...
09.07.2025Centivaxcentivax.com$92MUnited Sta...
12.01.2024Sentzsentz.com--
07.11.2023Gametogametogen.com$117MUnited Sta...
04.08.2023Lace Litho...lacelithography.com-Norway, Be...
22.07.2023GLASS Imag...glass-imaging.com$20MUnited Sta...
22.07.2023301 Moved ...zyphra.com-United Sta...
22.06.2023RobustAIrobust.ai$42.5MUnited Sta...
19.04.2023Enriched A...enriched.ag$9MUnited Sta...
Show more

Mentions in press and media 35

DateTitleDescription
29.06.2026Gaussion Raises $28M in FundingGaussion, a London, UK-based deep tech company advancing energy intelligence technology for battery packs, closed a $28m funding round. Gaussion CEO and co-founder Tom Heenan The round, which brought total capital raised to over $44m since ...
23.06.2026B612 Foundation Announces 2026 Winner of the Schweickart PrizeUniversity of Edinburgh Researchers Brian P. Murphy and Richard E. Cannon Recognized for Proposal to Expand Planetary Defense to Humanity's New Frontiers SAN FRANCISCO, June 23, 2026 /PRNewswire/ -- B612 Foundation announced the recipient o...
21.10.2025Faeth Therapeutics Secures $25M to Propel Cancer Metabolism TherapiesFaeth Therapeutics secured $25 million, raising its total capital to $92 million. This vital funding drives its lead PIKTOR program for endometrial cancer into Phase 2, following an impressive 80% response rate. It also expands the AI-drive...
20.10.2025Faeth Therapeutics: $25 Million Raised To Advance PIKTOR Phase 2 Trial Following 80% Response Rate In Endometrial CancerFaeth Therapeutics, a clinical-stage biotechnology company pioneering metabolism-based cancer therapies, announced a $25 million strategic financing round to advance its lead program, PIKTOR, in endometrial cancer. The raise brings Faeth’s ...
30.08.2025Fusion Energy Giant Secures $863 Million Investment from Tech LeadersCommonwealth Fusion Systems, a leader in fusion energy, raised $863 million in new funding. This major capital injection advances commercial fusion power. Prominent investors include Nvidia, Google, and Bill Gates' Breakthrough Energy Ventu...
28.08.2025Commonwealth Fusion Systems Raises $863 Million Series B2 Round to Accelerate the Commercialization of Fusion EnergyThis round of capital is the largest raised among deep tech and energy companies since CFS' $1.8 billion Series B round in 2021. The almost $3 billion that CFS has raised to date is about one-third of the total capital invested in private f...
27.08.2025Better Meat Co. Fuels Mycoprotein Future with $31M, Adds Biotech IconThe Better Meat Co. (BMC) successfully raised $31 million in Series A funding. This capital fuels the commercial scaling of its Rhiza™ mycoprotein. Rhiza™, a revolutionary fermentation-derived ingredient, significantly improves traditional ...
26.08.2025Biotech Leader Dr. Pamela Marrone Joins Better Meat Co. Board of DirectorsThe Better Meat Co. (BMC), a company focused on fermentation-derived ingredients for the food industry, has announced the addition of Dr. Pamela Marrone to its Board of Directors. Dr. Marrone, based in Davis, California, brings extensive ex...
19.08.2025Better Meat Co raises $31m Series A: ‘Some days, building a startup in our sector can feel like being a player in Squid Game’Sacramento-based startup The Better Meat Co (BMC) has closed a $31 million oversubscribed Series A round enabling it to increase production of its Rhiza mycoprotein to commercial scale and sell “at prices lower than US commodity ground beef...
19.08.2025The Better Meat Co. Secures $31 Million in Series A to Scale Mycoprotein ProductionThe Better Meat Co. (BMC), a company focused on developing mycoprotein ingredients, has successfully closed a $31 million Series A financing round. The round, which was oversubscribed, was co-led by Future Ventures and Resilience Reserve, w...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In